PhaseBio Pharmaceuticals Inc reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Malvern, PA
SEC filing record 1 source field available
Fiscal year end
31 December
PhaseBio Pharmaceuticals Inc has filed 371 SEC EDGAR filings since 25 Feb 2002

SEC filing history

Showing 1-6 of 6 matching filings.

Per page
25
Current page
1
SC 13D/A File 005-90691

NEW ENTERPRISE ASSOCIATES 13, LP (PHASEBIO PHARMACEUTICALS) - SCHEDULE 13D/A#1E

Filing date
04 Nov 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-90691

SC 13D/A

Filing date
29 Jul 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-90691

SC 13D/A

Filing date
08 Nov 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-90691

SC 13D

Filing date
01 Nov 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-90691

NEW ENTERPRISE ASSOC. 13, LP - PHASEBIO PHARMACEUTICALS, INC. -- SCHEDULE 13D

Filing date
31 Oct 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-90691

SC 13D

Filing date
29 Oct 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .